Skip to main content
. 2019 Mar 26;11(3):429. doi: 10.3390/cancers11030429

Figure 4.

Figure 4

The graph shows the cumulative survival of patients according to their average levels of exosomes with CD-63 (left) and CAV-1 (right) after resective surgery.